Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children

@article{Arican2006TopicalTO,
  title={Topical treatment of molluscum contagiosum with imiquimod 5\% cream in Turkish children},
  author={O. Arican},
  journal={Pediatrics International},
  year={2006},
  volume={48}
}
  • O. Arican
  • Published 2006
  • Medicine
  • Pediatrics International
Background: Molluscum contagiosum (MC) is caused by a poxvirus which produces cutaneous lesions appearing as small, firm, umblicated papules. Lesions of MC are most commonly seen in young children. Transmission is through viral particules, which remain on surfaces, autoinoculation, or from contact with open lesions. There are many options for treatment of MC and these may be broadly subdivided into destructive, immunological and antiviral therapies. An alternative treatment would be desirable… Expand
Pediatric molluscum contagiosum: reflections on the last challenging poxvirus infection, Part 2.
TLDR
Treatment of Molluscum contagiosum is recommended because of the high rate of associated symptoms, risk for transmissibility, and cosmetic or social concerns. Expand
An immunocompromised woman with severe molluscum contagiosum that responded well to topical imiquimod: a case report and literature review.
TLDR
A severe case of genital molluscum contagiosum is reported in a patient with Sjögren syndrome, whose vulvar lesions responded to topical 5% imiquimod cream. Expand
Update on the Treatment of molluscum Contagiosum in children.
TLDR
Treatment options for molluscum contagiosum in children can be challenging, particularly when the patient presents multiple lesions or when lesions are symptomatic or highly visible. Expand
Update on the Treatment of molluscum Contagiosum in children.
TLDR
Treatment options for molluscum contagiosum in children can be challenging, particularly when the patient presents multiple lesions or when lesions are symptomatic or highly visible. Expand
Interventions for cutaneous molluscum contagiosum.
TLDR
This is an update of a Cochrane Review to assess the effects of specific treatments and management strategies, including waiting for natural resolution, for cutaneous, non-genital molluscum contagiosum in people without immune deficiency. Expand
Molluscum Contagiosum: To Treat or Not to Treat? Experience with 170 Children in an Outpatient Clinic Setting in the Northeastern United States
TLDR
The demographic characteristics, clinical characteristics, management, and time to resolution of MC in 170 children, conducted in the Division of Pediatric Dermatology at the Johns Hopkins Children's Center, Baltimore, Maryland, from January 1, 2008, to December 31, 2011, are reviewed. Expand
Clinical and Demographic Characteristics of Patients with Molluscum Contagiosum Treated at the University Dermatology Clinic Maribor in a 5-year period.
Molluscum contagiosum virus (MCV) is a common skin pathogen in both adults and children. In this prospective study, we clinically evaluated consecutive patients with molluscum contagiosum (MC) whoExpand
Comparative Study on the Efficacy, Safety, and Acceptability of Imiquimod 5% Cream versus Cryotherapy for Molluscum Contagiosum in Children
TLDR
IMQ appears to be practically painless and more cosmetically accepted treatment when compared with cryotherapy, and may be the preferred treatment of MC in children especially with numerous small lesions. Expand
Zoonotic Brazilian Vaccinia virus: from field to therapy.
TLDR
The virological, epidemiological, ecological and clinical aspects of VACV infection, its diagnosis and compounds that potentially could be used for the treatment of severe cases are discussed. Expand
Cantharidin for the Treatment of Molluscum Contagiosum: A Prospective, Double‐Blinded, Placebo‐Controlled Trial
TLDR
This study provided objective unbiased estimates of the magnitude of cantharidin treatment effects and provided important prospective safety data. Expand
...
1
2
...

References

SHOWING 1-10 OF 16 REFERENCES
Treatment modalities for molluscum contagiosum
TLDR
Combination therapy has been more successful in such cases especially if treatment includes such experimental antiviral/immunomodulatory agents as imiquimod or cidofovir. Expand
Treatment of Molluscum Contagiosum with Topical 5% Imiquimod Cream
TLDR
5% imiquimod cream offers an effective and discomfort-free therapeutic alternative to treatment of molluscum contagiosum in pediatric patients, and is found to be effective in the treatment of basal cell carcinomas. Expand
Experience in treating molluscum contagiosum in children with imiquimod 5% cream
TLDR
The results of this study suggest that imiquimod 5% cream is a useful new treatment option for MC in children, especially in severe cases. Expand
Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum
TLDR
Topical immunomodulators include both immunostimulatory and immunosuppressive agents, which have been clinically used to treat viral infections such as human papillomavirus, herpes simplex virus and mollusca in immunocompetent and Immunosuppressed patients. Expand
Treatment of molluscum contagiosum with imiquimod 5% cream.
  • R. Skinner
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2002
TLDR
5 immunocompetent patients with molluscum contagiosum who were successfully treated with imiquimod 5% cream are described. Expand
Insights into a novel treatment for molluscum
TLDR
The promising efficacy rate and low irritant potential of imiquimod may make this an effective and pain-free treatment modality for a commonly encountered problem. Expand
Imiquimod Therapy for Molluscum Contagiosum
TLDR
Although topical imiquimod appears to have some efficacy in the therapy of MCV, in children the pruritus correlated relatively well with the development of new lesions, in adults, areas that would be expected to have better penetration appeared to respond more consistently. Expand
An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
TLDR
Imiquimod 5% cream appears to be a safe treatment in children with molluscum contagiosum, and there is no evidence of systemic toxicity. Expand
Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.
TLDR
Imiquimod was well tolerated and appears to be a promising therapeutic option in the treatment of MC in children, according to the results of this small pilot study. Expand
Efficacy of Imiquimod 5% Cream in the Treatment of Recalcitrant Warts in Children
TLDR
It is demonstrated that the topical application of imiquimod 5% cream is an effective treatment for long‐lasting cutaneous warts in children. Expand
...
1
2
...